Oracle Introduces Oracle Health Sciences Data Management

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Oracle Introduces Oracle Health Sciences Data Management Workbench to Aggregate, Reconcile and Transform Disparate Sources of Clinical Trial Data

REDWOOD SHORES, CA--(Marketwired - Jun 16, 2014) - Oracle ( NYSE : ORCL )

News Summary Life sciences organizations running clinical trials are challenged to aggregate, reconcile, manage, and control a growing deluge of data from internal and external sources. In addition, clinical development is an increasingly networked and collaborative discipline across companies, which further complicates the data management landscape. These factors, as well as continued pressure to boost clinical program productivity and reduce the cost and risk of clinical trials, are driving a critical need for a new approach to clinical data management and warehousing. Oracle introduced Oracle Health Sciences Data Management Workbench to help meet these needs. 

Using Oracle Health Sciences Data Management Workbench, researchers can integrate, reconcile and analyze clinical data faster and more accurately, which automates data load, transform and cleanse processes. As a result, study sponsors can make faster, more informed decisions that improve control, support adaptive studies and accelerate clinical trials and time to market. 

News Facts

  • Oracle Health Sciences Data Management Workbench enables health sciences organizations to accelerate clinical studies and boost program productivity while helping to drive down the cost and risk of clinical trials.
  • The solution, which is integrated with Oracle Life Sciences Data Hub , automatically aggregates, integrates and reconciles the rapidly growing volume of data that clinical trials collect from internal and external data sources, including electronic data capture, laboratory, safety/pharmacovigilance, and drug supply systems. By doing so, it helps dramatically decrease the complexity of data management and reduce the cost of clinical trials.
  • In addition, the solution automates the normalization and transformation of multi-source data to create a single source of truth for all stakeholders in the clinical development process and helps enable rapid analysis to drive faster, more informed decisions.
  • By providing this standardized data transformation, Oracle Health Sciences Data Management Workbench helps significantly increase efficiency by enabling researchers to pool data from multiple studies for program development and submission.
  • Also, by increasing data integration and standardizing data formats throughout the study process, Oracle Health Sciences Data Management Workbench automates the identification and correction of discrepancies in multi-source data that can jeopardize the validity of a study. As a result, the solution helps reduce costs and accelerate database lock.
  • The standardized data formats used within the system are repeatable and reusable, which reduces the time and cost of trial set-up.
  • Using Oracle Health Sciences Data Management Workbench, organizations can also streamline compliance thanks to full traceability of data discrepancies as well as comprehensive security and audit trail capabilities.
  • Focused on helping health sciences organizations of all sizes create clinical trial management environments that increase efficiency and can scale with their needs, Oracle Health Sciences Data Management Workbench integrates with Oracle Health Sciences InForm to enable automated, bi-directional and real-time information flow between the systems. The integration helps improve data integrity across the enterprise and virtually eliminates the need to rekey data.

Supporting Quote

"As the industry's only true end-to-end data management solution, Oracle Health Sciences Data Management Workbench enables health sciences organizations to improve clinical program productivity and reduce costs and risk by reducing study cycle times, improving data quality and decision making," said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences.

Supporting Resources

About Oracle Oracle engineers hardware and software to work together in the cloud and in your data center. For more information about Oracle ( NYSE : ORCL ), visit www.oracle.com .

Trademarks Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info Greg Lunsford Oracle +1.650.506.6523 Email Contact Mary Tobin O'Keeffe & Company +1.503.658.7396 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

US Foods Faces Major Strike Threat Over Driver Contracts

Updated Category News Views 84

Teamsters Prep for Possible Strike Against US Foods You can almost hear the union drums beating as 260 drivers from Teamsters Local 282 in New York gear up for what could be a major confrontation with US Foods. The message is loud and clear: pay us what we're worth, or watch your delivery chain grind to a halt. With unanimous approval to strike, this isn't just a...

Continue Reading
PMET Grows Mineral Assets at Shaakichiuwaanaan

Updated Category News Views 100

Resource Expansion at the Shaakichiuwaanaan Property You ever see a resource report that makes you do a double take? That's the vibe here with PMET's game-changing update on their Shaakichiuwaanaan property in Quebec. They've crunched the numbers at the Helios Caesium Zone and CV4 Pegmatite, and the results? A juicy increase in the grade, scale, and tonnage across three...

Continue Reading
GNSS Simulator Market: $425M by 2031, Key Insight

Updated Category News Views 118

GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...

Continue Reading
EAF Relief Fund Launches After Learjet Disaster

Updated Category News Views 103

Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...

Continue Reading
RSPO RT2026 Tackles Indonesian Fires and Export Shifts

Updated Category News Views 15

Indonesia's Burning Questions There's been a lot of smoke—literally and figuratively—hanging over the palm oil industry in Indonesia this year. At the RSPO's Annual Roundtable on Sustainable Palm Oil (RT2026), attendees didn't shy away from addressing the harsh realities. In a year marked by rampant fires, thanks to the blistering El Niño, the RSPO showcased data...

Continue Reading
Staypineapple Backs Vets: A Heartwarming Initiative

Updated Category News Views 151

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

Continue Reading
HashKey and AMBR Unite to Push AI Frontiers in Finance

Updated Category News Views 34

Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...

Continue Reading
Verismo's SynKIR-110: Revolutionizing CAR T Therapy?

Updated Category News Views 73

Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...

Continue Reading
Silvercorp Updates El Domo Budget Amid Challenges

Updated Category News Views 78

Budget Pains for Silvercorp's El Domo Project Folks, if you thought navigating the stock market was a minefield, try mining these days. Silvercorp Metals Inc. had to bump up its budget for the El Domo project in Ecuador—again. This time by $14.6 million. What's causing this fiscal heartache? Everything from rising diesel prices thanks to Ecuador playing games with...

Continue Reading
BD Appoints Bagnato as Peripheral Intervention Head

Updated Category News Views 13

A New Captain for BD's Peripheral Ship Time to pay attention, folks. Franklin Lakes just sent an interesting ripple through their workforce headlines, announcing Bridget Bagnato taking the reins as Worldwide President of BD's Peripheral Intervention division. Come November 16, this medical tech veteran, who's clocked over 27 years with BD, is set to start steering their...

Continue Reading

Top 5 Most Recently Viewed Articles

SEATOM Selected for NATO's Accelerator Programme Growth

Updated Category News Views 161

SEATOM's Selection for NATO's Accelerator Programme Today, SEATOM announced a significant milestone as it was chosen to participate in the NATO Defence Innovation Accelerator for the North Atlantic (DIANA) 2026 Challenge Programme. This prestigious selection underscores SEATOM's innovative approach to developing nuclear technology tailored for maritime and extreme...

Continue Reading
OpenAI's New Device Development Following $6.5 Billion Acquisition

Updated Category News Views 194

OpenAI Completes a Major Acquisition OpenAI has recently wrapped up a remarkable deal by acquiring Jony Ive's AI hardware startup, io Products, for a staggering $6.5 billion. This acquisition brings the design genius, renowned for his work at a major tech giant, into OpenAI's fold to help create a new generation of smart devices. Key Developments Post-Acquisition The...

Continue Reading
Opportunities for KinderCare Investors Amid Class Action News

Updated Category News Views 151

Opportunities for KinderCare Investors Robbins Geller Rudman & Dowd LLP has announced a significant opportunity for investors of KinderCare Learning Companies, Inc. (NYSE: KLC) who have experienced substantial losses. This is a pivotal moment for shareholders as they can now seek to lead a class action lawsuit against the company. Understanding the Class Action Lawsuit...

Continue Reading
Baltic Horizon Fund Sees Positive NAV Growth in May 2025

Updated Category News Views 128

Growth of Baltic Horizon Fund's NAV in May 2025 The Baltic Horizon Fund reported an increase in its net asset value (NAV) per unit, which rose to EUR 0.6757 at the close of May 2025. This figure represents a slight gain from the NAV of EUR 0.6740 recorded at the end of April 2025. The fund's overall net asset value reached EUR 97.0 million, up from EUR 96.8 million in the...

Continue Reading
Autolus Therapeutics Highlights CARLYSLE Trial Findings at ASH 2025

Updated Category News Views 239

Autolus Therapeutics Showcases CARLYSLE Trial Results Autolus Therapeutics plc (Nasdaq: AUTL), a biopharmaceutical leader in developing innovative T cell therapies, recently showcased promising preliminary data from the CARLYSLE trial, which focuses on severe refractory systemic lupus erythematosus (srSLE). The data were presented during a special session at a leading...

Continue Reading